Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)
September 07 2016 - 4:11PM
Edgar (US Regulatory)
Filed Pursuant to Rule 433
Registration Statement No. 333-209867
Thermo Fisher Scientific Inc.
Term Sheet
September 7, 2016
0.750% Senior Notes due 2024
|
Issuer:
|
Thermo Fisher Scientific Inc.
|
|
Legal Format:
|
SEC Registered
|
|
Security:
|
0.750% Notes due 2024
|
|
Principal Amount:
|
€1,000,000,000
|
|
Maturity Date:
|
September 12, 2024
|
|
Coupon (Interest Rate):
|
0.750% per annum, paid annually
|
|
Spread to Mid-Swap:
|
+80 basis points
|
|
Yield to Maturity:
|
0.864%
|
|
Benchmark Bund:
|
DBR 1.0% due 15-Aug 2024
|
|
Benchmark Bund Yield/Price:
|
-0.373% / 111.07%
|
|
Spread to Benchmark Bund:
|
+123.7 basis points
|
|
Interest Payment Dates:
|
September 12 of each year, commencing on September 12, 2017
|
|
Day Count Convention:
|
Actual/Actual (ICMA)
|
|
Business Days:
|
New York, London, TARGET2
|
|
Payment Business Day Convention:
|
Following, unadjusted
|
|
Redemption Provision:
|
Prior to June 12, 2024 (three months prior to their maturity), the issuer will have the option to redeem the notes, in whole at any time or in part
from time to time, at a redemption price equal to the greater of (1) 100% of the principal amount of the notes to be redeemed and (2) the sum of the present values of the remaining scheduled payments of the notes
|
|
|
being redeemed, that would be due if such notes matured on June 12, 2024 (three months prior to their maturity) but for the redemption (not including any portion of the payments of interest
accrued but unpaid as of the date of redemption) discounted to the date of redemption on an annual basis (ACTUAL/ACTUAL (ICMA)), using a discount rate equal to the Comparable Bond Rate plus 20 basis points, plus accrued and unpaid interest thereon,
if any, to, but excluding, the redemption date. In addition, on and after June 12, 2024 (three months prior to their maturity), the issuer will have the option to redeem the notes, in whole at any time or in part from time to time, at a
redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the date of redemption.
|
|
Underwriting Discount:
|
0.375%
|
|
Net Proceeds, Before Expenses, to Issuer:
|
€987,470,000
|
|
Settlement Date:
|
September 12, 2016 (T+3)
|
|
Trade Date:
|
September 7, 2016
|
|
Current Ratings*:
|
Moody’s: Baa2 (Stable)
|
|
Currency of Payment:
|
All payments of principal of, and premium, if any, and interest on, the notes, including any payments made upon any redemption of the notes, will be
made in euro. If the euro is unavailable to the issuer due to the imposition of exchange controls or other circumstances beyond the issuer’s control or if the euro is no longer being used by the then member states of the European Monetary Union
that have adopted the euro as their currency or for the settlement of transactions by public institutions of or within the international banking
|
|
|
community, then all payments in respect of the notes will be made in U.S. dollars until the euro is again available to the issuer or so used.
|
|
Payment of Additional Amounts:
|
The issuer will, subject to certain exceptions and limitations, pay to the beneficial owners of the notes who are Non-U.S. Persons, additional amounts as may be necessary so that every net payment of the principal of, and premium, if any, and
interest on, such holder’s note after deduction or withholding for or on account of any present or future tax, assessment or other governmental charge imposed upon that holder by the United States (or any political subdivision or taxing
authority thereof or therein), will not be less than the amount provided in such holder’s note to be then due and payable.
|
|
Redemption for Tax Reasons:
|
The issuer may redeem all, but not less than all, of the notes in the event of certain changes in the tax laws of the United States (or any political subdivision or taxing authority thereof or therein) which would create a material probability
that the issuer would be obligated to pay additional amounts as described above. This redemption would be made on at least 15 days’ but not more than 60 days’ notice and at a redemption price equal to 100% of the principal amount of the
notes, plus any accrued and unpaid interest on the notes to, but not including, the date fixed for redemption.
|
|
Purchase of Notes Upon a Change of Control Triggering Event:
|
Upon the occurrence of a Change of Control Triggering Event, the issuer will, in certain circumstances, be required to make an offer to purchase the notes at a price equal to 101% of their principal amount plus any accrued and unpaid interest,
if any, to, but excluding, the date of repurchase.
|
|
Denominations:
|
€100,000 x €1,000
|
|
ISIN/Common Code:
|
XS1405775708 / 140577570
|
|
Listing:
|
The issuer intends to apply to list the notes on the New York Stock Exchange. Upon such
|
|
|
listing, the issuer will use commercially reasonable best efforts to maintain such listing and satisfy the requirements for such continued listing as long as the notes are outstanding.
|
|
Joint Book-Running Managers:
|
J.P. Morgan Securities plc
|
Morgan Stanley & Co. International plc
|
|
Credit Suisse Securities (Europe) Limited
|
|
|
Merrill Lynch International
|
|
Co-Managers:
|
BNY Mellon Capital Markets, LLC
|
|
|
Citigroup Global Markets Limited
|
|
|
Deutsche Bank AG, London Branch
|
|
|
ING Bank N.V., Belgian Branch
|
|
|
KeyBanc Capital Markets Inc.
|
|
|
SMBC Nikko Capital Markets Limited
|
|
|
U.S. Bancorp Investments, Inc.
|
|
|
Wells Fargo Securities International Limited
|
|
*
|
A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time. Credit ratings are subject to change depending on financial and other factors.
|
The offering is being made pursuant to an effective registration statement on Form S-3 (including a prospectus) filed with the U.S.
Securities and Exchange Commission (the “SEC”). Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this
offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the joint book-running managers can arrange to send you the prospectus if you request it by calling J.P. Morgan Securities plc at +44
207-134-2468; or by calling Barclays Bank PLC at 1-888-603-5847; or by calling Mizuho International plc at +44 207-090-6929; or by calling Morgan Stanley & Co. International plc at 1-866-718-1649.
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Thermo Fisher Scientific (NYSE:TMO)
Historical Stock Chart
From Apr 2023 to Apr 2024
